Novozymes A/S (NVZMY)
Makes enzymes that help food, cleaning, energy, and agriculture companies work better.
$64.41+0.05%Basic Materials
StockGlow Score
Bullish
BearishBullish
1 year ago-1.2%
The outlook
NVZMY is trading near the upper end of its 52-week range and above both its 50- and 200-day moving averages, showing upward price momentum. Analyst coverage is thin with just two analysts, both leaning Buy; their average price target sits about 13% above the current price. The stock trades at a trailing P/E of 44.1, notably elevated relative to typical valuations.
What’s behind the score
Analyst consensusBuy — 1.7 avg of 2 analysts
Price trendAbove its 50- & 200-day averages
52-week range79% of the way from its 52-week low to high
Price targetAvg target +13% vs current price
Analyst price target
~12-month · 2 analysts$73.00average target+13.3% vs now
Now $64.41
Low $63.00High $83.00
Published targets from Wall Street analysts (public data) — what analysts expect over roughly a year. This is not a StockGlow forecast and not a recommendation. Analyst targets are frequently wrong.
Market cap
$30.03B
52-wk high
$68.19
52-wk low
$49.90
50-day avg
$61.02
200-day avg
$61.06
Trailing P/E
44.1